Last reviewed · How we verify

NCT05838807

Thermal and Pulsed Ultrasound for Carpal Tunnel Syndrome

Completed NA Last updated 2 April 2024
What this trial tests

NA trial testing Thermal Ultrasound in Carpal Tunnel Syndrome in 92 participants. Completed in 14 March 2024.

Timeline
28 May 2023
Primary endpoint
14 March 2024
14 March 2024

Quick facts

Lead sponsorAhram Canadian University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment92
Start date28 May 2023
Primary completion14 March 2024
Estimated completion14 March 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ahram Canadian University

Who can join

Adults 30 to 60, any sex, with Carpal Tunnel Syndrome or Median Neuropathy, Carpal Tunnel. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be a Randomized controlled trial with a sample size of at least 100 individuals with carpal tunnel syndrome. Participants will be randomized to receive either thermal ultrasound, pulsed ultrasound, a combination of both, or a placebo treatment for 10 minutes, three times per week, for 4 weeks. Outcome measures will include pain intensity, functional status, and nerve conduction studies. Outcome measures will be assessed at baseline, 4 weeks, and 8 weeks.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Carpal Tunnel Syndrome

Currently open trials in the same condition.

Other Ahram Canadian University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05838807.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing